← Issue №20/ week of Nov 15, 2026/Hepatology

TIPS for refractory hepatic hydrothorax in patients with cirrhosis: impact of clinical response on survival.

From GI Signals issue №20: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Hepatology retrospective · n=147 · Nov 11, 2026 · Clin Gastro Hep · IF 16.2

TIPS for refractory hepatic hydrothorax in patients with cirrhosis: impact of clinical response on survival.

New evidencecirrhosisportal hypertensionhepatic encephalopathyascites
Clinical takeawayIn patients selected for TIPS for refractory hydrothorax, expect complete response in about 60%; complete response was independently associated with lower mortality (HR 0.30, 95% CI 0.14-0.64), but the 147-patient series had no comparison group without TIPS.
What it foundTIPS achieved complete response (disappearance of symptoms and no further thoracenteses) in 60% of patients with refractory hepatic hydrothorax, with mortality rates of 1.54, 5.34, and 11.4 deaths per 100 patient-months in complete, partial, and no response groups, respectively.
ContextThis study provides evidence supporting TIPS as a potential option for refractory hepatic hydrothorax, though further research is needed to confirm its role in improving survival outcomes.
Emergingsuggested applicable standard· AASLD, 'Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis', Hepatology 2024 (PMID 37870298) - current AASLD guidance for the portal-hypertension context in which TIPS is indicated. Procedure-specific: AASLD 'The Role of TIPS in the Management of Portal Hypertension' (Boyer & Haskal), Hepatology 2010, doi 10.1002/hep.23383.

TIPS is a percutaneous interventional-radiology procedure that creates a covered (PTFE-preferred) shunt between portal and hepatic veins to decompress portal hypertension, indicated for refractory ascites (Child-Pugh A/B, MELD <18), refractory variceal hemorrhage, EARLY/pre-emptive placement within 72 h for Child-Pugh C ≤13 (or Child-Pugh B with active bleeding) at index EGD, Budd-Chiari syndrome, and select other decompensation states. …

From our summary of this standard, unedited — the part the paper bears on. … marks omitted text. Our wording, not the guideline's; read the source for its own text.

Our full summary of this standard

TIPS is a percutaneous interventional-radiology procedure that creates a covered (PTFE-preferred) shunt between portal and hepatic veins to decompress portal hypertension, indicated for refractory ascites (Child-Pugh A/B, MELD <18), refractory variceal hemorrhage, EARLY/pre-emptive placement within 72 h for Child-Pugh C ≤13 (or Child-Pugh B with active bleeding) at index EGD, Budd-Chiari syndrome, and select other decompensation states. HVPG is measured pre/post with a target reduction ≥20% or HVPG ≤12 mmHg. All patients require pre-procedure cardiac/pulmonary/renal/LT evaluation. Post-procedure encephalopathy prophylaxis (e.g., lactulose and/or rifaximin) should be individualized based on risk factors such as prior HE, age >65, or severe liver dysfunction, with Doppler surveillance for stent dysfunction.

AASLD, 'Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis', Hepatology 2024 (PMID 37870298) - current AASLD guidance for the portal-hypertension context in which TIPS is indicated. Procedure-specific: AASLD 'The Role of TIPS in the Management of Portal Hypertension' (Boyer & Haskal), Hepatology 2010, doi 10.1002/hep.23383. · reviewed 2026-07-21 ↗
Tizzani M … “TIPS for refractory hydrothorax in cirrhosis” study investigators team · Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association · IF 16.2 · PubMed ↗Permalink
← Read the whole of issue №20 Every paper GI Signals surfaces gets a page like this one. All issues